Can we prevent cochlear implant recipients from developing pneumococcal meningitis?

Clinical Infectious Diseases

Volumn 46, Issue 1, 2008, Pages

  Wei, Benjamin P C ^a,b   Robins Browne, Roy M ^b   Shepherd, Robert K ^a   Clark, Graeme M ^a,b   O'Leary, Stephen J ^a,b  

^a BIONIC EAR INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIAL MENINGITIS; COCHLEA PROSTHESIS; DEVICE THERAPY; DRUG EFFICACY; EAR INJURY; EXPERIMENTAL MODEL; FOOD AND DRUG ADMINISTRATION; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; INCIDENCE; INFECTION PREVENTION; INNER EAR DISEASE; MEDICAL RESEARCH; MEDICAL SPECIALIST; PEDIATRICIAN; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION;

ANTIBIOTIC PROPHYLAXIS; COCHLEAR IMPLANTS; EQUIPMENT CONTAMINATION; HEARING; HUMANS; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 39349108562     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524083     Document Type: Review

References (50)

1. US Food and Drug Administration. Public health web notification: risk of bacterial meningitis in children with cochlear implants. 6 February 2006. Available at http://www.fda.gov/cdrh/safety/020606-cochlear.html. Accessed 10 June 2007.
2. Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med 2003; 349:435-45.
3. Cohen NL, Roland JT Jr, Marrinan M. Meningitis in cochlear implant recipients: the North American experience. Otol Neurotol 2004; 25:275-81.
4. Angeli S, Balkany T. Post-cochlear implant meningitis. Operative Techniques in Otolaryngology-Head and Neck Surgery 2003; 14:293-6.
5. Biernath K, Reefhuis J, Whitney CG, Mann EA, Costa P, Boyle C. Bacterial meningitis in children with cochlear implants after twenty-four months post-implantation. Am J Epidemiol 2005; 161:S152-2.
6. Biernath KR, Reefhuis J, Whitney CG, et al. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics 2006; 117:284-9.
7. Meli DN, Christen S, Leib SL, Tauber MG. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis 2002; 15:253-7.
8. Clark G. Cochlear implants in children: safety as well as speech and language. Int J Pediatr Otorhinolaryngol 2003; 67:S7-20.
9. Clark GM. Cochlear implants fundamentals & application. New York: Springer-Verlag, 2003.
10. Bluestone CD. Prevention of meningitis: cochlear implants and inner ear abnormalities. Arch Otolaryngol Head Neck Surg 2003; 129:279-81.
11. Arnold W, Bredberg G, Gstottner W, et al. Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments. ORL J Otorhinolaryngol Relat Spec 2002; 64:382-9.
12. Schuknecht HF. Pathology of ear. 2nd ed. Malvern, PA: Lea & Febiger, 1993.
13. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Investig 1998; 102:347-60.
14. Igarashi M, Saito R, Alford R, Filippone M, Smith JA. Temporal bone findings in pneumococcal meningitis. Arch Otolaryngol 1974; 99:79-83.
15. Wei BPC, Shepherd RK, Robins-Browne R, Clark G, O'Leary SJ. Pneumococcal meningitis: development of a new animal model. Otol Neurotol 2006; 27:844-54.
16. Wei BPC, Shepherd RK, Robins-Browne R, Clark G, O'Leary SJ. Pneumococcal meningitis threshold model: a potential tool to assess infectious risk of new or existing inner ear surgical interventions. Otol Neurotol 2006; 27:1152-61.
17. Moxon ER, Smith AL, Averill DR, Smith DH. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis 1974; 129:154-62.
18. Moxon ER, Ostrow PT. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis 1977; 135:303-7.
19. Roos KL, Tyler KL. Meningitis, encephalitis, brain abscess, and empyema. In: Kasper DL, Braunwald E, Fauci AS, et al., eds. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill, 2005: 2471-90.
20. Chavez-Bueno S, McCracken GH. Bacterial meningitis in children. Pediatr Clin North Am 2005; 52:795-810.
21. Franz B, Clark GM, Bloom D. Permeability of the implanted round window membrane in the cat- an investigation using horseradish peroxidase. Acta Otolaryngol 1984; (Suppl 410):17-23.
22. Wei BPC, Shepherd RK, Robins-Browne R, Clark G, O'Leary SJ. Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis post implantation. Otolaryngol Head Neck Surg 2007; 136:589-96.
23. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Investig 1984; 73:1191-200.
24. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487-97.
25. Fabre T, Belloc F, Dupuy B, et al. Polymorphonuclear cell apoptosis in exudates generated by polymers. J Biomed Mater Res 1999; 44:429-35.
26. Wardrop P, Whinney D, Rebscher SJ, Luxford W, Leake P. A temporal bone study of insertion trauma and intracochlear position of cochlear implant electrodes. II. Comparison of Spiral Clarion (TM) and HiFocus II (TM) electrodes. Hear Res 2005; 203:68-79.
27. Aschendorff A, Klenzner T, Richter B, Kubalek R, Nagursky H, Laszig R. Evaluation of the HiFocus electrode array with positioner in human temporal bones. J Laryngol Otol 2003; 117:527-31.
28. Aschendorff A, Klenzner T, Hamad M, Kubalek R, Richter B, Laszig R. Perimodiolar electrodes - radiological and histological findings. International congress series 2003; 1240:361-4.
29. Richter B, Aschendorff A, Lohnstein P, Husstedt H, Nagursky H, Laszig R. Clarion 1.2 standard electrode array with partial space-filling positioner: radiological and histological evaluation in human temporal bones. J Laryngol Otol 2002; 116:507-13.
30. Gstoettner WK, Adunka O, Franz P, et al. Perimodiolar electrodes in cochlear implant surgery. Acta Otolaryngol 2001; 121:216-9.
31. Tykocinski M, Cohen LT, Pyman BC, et al. Comparison of electrode position in the human cochlea using various perimodiolar electrode arrays. Am J Otol 2000; 21:205-11.
32. Wei BPC, Shepherd RK, Robins-Browne R, Clark G, O'Leary SJ. Effects of inner ear trauma on the risk of pneumococcal meningitis. Arch Otolaryngol Head Neck Surg 2007; 133:250-9.
33. Wei BPC, Robins-Browne RM, Shepherd RK, Azzopardi K, Clark GM, O'Leary SJ. Assessment of the protective effect of pneumococcal vaccination in preventing pneumococcal meningitis after cochlear implantation. Arch Otolaryngol Head Neck Surg 2007; 133:987-94.
34. Paleri V. Inner ear immunology and allergy: an overview of current day concepts. Ear Nose Throat J 1997; 76:799-802, 807-8, 810.
35. Ryan AF, Gloddek B, Harris JP. Lymphocyte trafficking to the inner ear. Ann NY Acad Sci 1997; 830:236-42.
36. Ryan AF. Summary: progress in inner-ear immunology. Ann NY Acad Sci 1997; 830:326-9.
37. Bluestone CD. Bacterial meningitis in children with cochlear implants. N Engl J Med 2003; 349:1772-3.
38. Hey C, Rose MA, Kujumdshiev S, Gstoettner W, Schubert R, Zielen S. Does the 23-valent pneumococcal vaccine protect cochlear implant recipients? Laryngoscope 2005; 115:1586-90.
39. Rose M, Hey C, Kujumdshiev S, Gall V, Schubert R, Zielen S. Immunogenicity of pneumococcal vaccination of patients with cochlear implants. J Infect Dis 2004; 190:551-7.
40. Jakobsen H, Sigurdsson VD, Sigurdardottir S, Schulz D, Jonsdottir I. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model. Infect Immun 2003; 71:2956-9.
41. Posfay-Barbe KM, Wald ER. Pneumococcal vaccines: do they prevent infection and how? Curr Opin Infect Dis 2004; 17:177-84.
42. Kamerling JP. Pneumococcal polysaccharides: a chemical view. In: Tomasz A, ed. Streptococcus pneumoniae: molecular biology & mechanisms of disease. New York: Mary Ann Liebert, 2000:81-114.
43. Wei BPC, Robins-Browne RM, Shepherd RK, Azzopardi K, Clark GM, O'Leary SJ. Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation. Laryngoscope 2006; 116:2138-44.
44. Whitney CG. Cochlear implants and meningitis in children. Pediatr Infect Dis J 2004; 23:767-8.
45. Kennedy RJ, Shelton C. Ventilation tubes and cochlear implants: what do we do? Otol Neurotol 2005; 26:438-41.
46. Luntz M, Teszler CB, Shpak T. Cochlear implantation in children with otitis media: second stage of a long-term prospective study. Int J Pediatr Otorhinolaryngol 2004; 68:273-80.
47. Luntz M, Teszler CB, Shpak T, Feiglin H, Farah-Sima'an A. Cochlear implantation in healthy and otitis-prone children: a prospective study. Laryngoscope 2001; 111:1614-8.
48. Cohen N, Ramos A, Ramsden R, et al. International consensus on meningitis and cochlear implants. Acta Otolaryngologica 2005; 125:916-7.
49. O'Donoghue G, Balkany T, Cohen N, Lenarz T, Lustig L, Niparko J. Meningitis and cochlear implantation. Otol Neurotol 2002; 23:823-4.
50. Bluestone CD. Cochlear malformations, meningitis, and cochlear implants: what have we learned? Otol Neurotol 2003; 24:349-50.